To buy shares in Calliditas Therapeutics AB American Depositary Shares you will need a US based stock trading platform like Interactive Brokers or Moomoo where it currently costs $40 to buy one share in Calliditas Therapeutics AB American Depositary Shares (as of 20/09/2024 20:00). Which is a change of $0.04 or 0.1% from the last closing price of $40.04.
How To Buy Calliditas Therapeutics AB American Depositary Shares Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in Calliditas Therapeutics AB American Depositary Shares:
- Pick a stock broker (jump down to compare the best brokers for buying Calliditas Therapeutics AB American Depositary Shares stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:CALT)
- Choose the number of shares you want to buy (1 share currently costs $40)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your Calliditas Therapeutics AB American Depositary Shares stock in your account (this will show your profit and loss)
[qmod detailedquotetabchart CALT:US name=”Calliditas Therapeutics AB American Depositary Shares” show_profile=”1″ ticker=”CALT” heading=”h2″]
- Calliditas Therapeutics AB American Depositary Shares is currently worth $12,347,940,000 based on the last closing price of $40.04 with 9,796 shares traded.
- The most recent Calliditas Therapeutics AB American Depositary Shares daily high has been $43 and daily low $40.
- The Calliditas Therapeutics AB American Depositary Shares stock price 52 week high has been $43 and the 52 week low $15.25.
Compare Brokers For Buying Calliditas Therapeutics AB American Depositary Shares Stock
Is Now A Good Time To Buy Calliditas Therapeutics AB American Depositary Shares Stock?
- Calliditas Therapeutics AB American Depositary Shares’s EPS (earnings per share) are -1.76. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- Calliditas Therapeutics AB American Depositary Shares’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below Calliditas Therapeutics AB American Depositary Shares share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold. Subscribe to Good Money Guide Analysis for expert opinion on the latest investment opportunities.
[qmod analyst|earnings|financials|financialsummary|pricehistory|interactivechart|dividends|corporateevents|shareinfoperformance|fullnews|companyprofile CALT:US name=”Calliditas Therapeutics AB American Depositary Shares” show_profile=”1″ ticker=”CALT” heading=”h2″]



